This article is archived and only made available for historical reference. If you’d like to discover UCSF’s most recent advances in research, education and patient care, please visit the UCSF News Center.
Archive: RAP Offers HIV-Associated Malignancies Research Funding Opportunity
AIDS-defining and non-AIDS defining malignancies are emerging as a major source of morbidity and mortality among HIV-positive men and women.
The Resource Allocation Program (RAP) is providing this funding opportunity to stimulate research on HIV-associated malignancies and to foster multidisciplinary collaborations between the UCSF-Gladstone Institute of Virology and Immunology Center for AIDS Research (CFAR) investigators and the UCSF Helen Diller Family Comprehensive Cancer Center members by supporting one-year pilot research projects in HIV-associated malignancies.
The application deadline is Friday, Jan. 8, 2010. Results of this competition will be available in January 2010.
Each project will be required to have a CFAR member, and a cancer center co-investigator.
Pilot studies may be funded to a maximum of $75,000, and may include the following:
- Basic research
- Translational and clinical research on the etiology
- Pathogenesis
- Prevention and management of AIDS-defining and non-AIDS defining malignancies.
This is a special off-cycle RAP funding opportunity, and these applications are only accepted online through the RAP website.